The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Anticipated Rise In Market Value Of The Antisense & RNAi Therapeutics Market During The Forecast Period?
The antisense & rnai therapeutics market size has seen swift expansion in recent years. It is anticipated to increase from $1.93 billion in 2025 to $2.17 billion in 2026, representing a compound annual growth rate (CAGR) of 12.6%. The historical growth of this market is attributable to the early adoption of antisense therapies, initial rnai research breakthroughs, the progression of oligonucleotide synthesis techniques, a growing need for targeted therapeutics, and investments in biotech research.
The antisense & rnai therapeutics market size is anticipated to experience swift expansion over the coming years. It is projected to reach $3.53 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.9%. The expected growth within this forecast period is attributed to advancements in delivery technologies, the expanding field of precision medicine, integration with AI-driven drug discovery, an increase in RNAi-based clinical trials, and rising healthcare investments in emerging markets. Significant trends for the forecast period include targeted gene silencing, novel delivery mechanisms, personalized therapeutics, nucleic acid stabilization techniques, and progress in regulatory and clinical areas.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3389&type=smp
What Key Drivers Are Fueling The Growth Of The Antisense & RNAi Therapeutics Market?
The increasing incidence of coronary artery diseases, neurodegenerative disorders, and infectious diseases is expected to boost the demand for the antisense & RNAi therapeutics market. Gene suppression methods like RNA interference and antisense oligonucleotides are utilized to treat various neurodegenerative conditions by mending mutant genes. As an illustration, a January 2024 report by the American Heart Association, a US-based organization, stated that the age-adjusted death rate from cardiovascular diseases escalated to 233.3 per 100,000, marking a 4.0% increase from the previous year. Thus, the rising prevalence of several neurodegenerative and infectious diseases is anticipated to propel the growth of the antisense & RNAi therapeutics market.
How Is The Antisense & RNAi Therapeutics Market Broken Down By Segment Categories?
The antisense & rnai therapeutics market covered in this report is segmented –
1) By Technology: RNA Interference, Antisense RNA
2) By Route Of Administration: Intravenous Injections, Intra-dermal Injections, Other Delivery Methods
3) By Indication: Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological Disorders, Infectious Diseases, Other Indications
Subsegments:
1) By RNA Interference (RNAi): Small Interfering RNA (siRNA), Short Hairpin RNA (shRNA), Dicer-substrate siRNA, MicroRNA (miRNA) Based Therapeutics
2) By Antisense RNA: Antisense Oligonucleotides (ASOs), Morpholino Oligomers, Locked Nucleic Acids (LNAs), Gapmer Antisense Oligonucleotides
What Trends Are Affecting The Direction Of The Antisense & RNAi Therapeutics Market?
Major companies operating in the antisense & RNAi therapeutics market are engaging in strategic initiatives, such as collaborations and partnerships, to sustain their presence in the increasingly competitive market. Strategic collaboration represents a business strategy that involves two or more companies working together to achieve a common goal or objective. For instance, in January 2023, Orbit Discovery Limited, a US-based company providing services for peptide discovery, partnered with SanegeneBio Inc., a UK-based company involved in developing novel RNAi-based medicines. This partnership aims at identifying tissue-specific delivery of RNA therapeutics for efficient gene knockdown, with the objective of developing a portfolio of advanced RNAi therapeutics. The collaboration includes hit identification and cell-based internalization studies, with Sanegene having the option to further develop the hits derived from the screening activities, leveraging Orbit’s proprietary technology for rapid peptide lead discovery. Orbit Discovery’s unique peptide display engine facilitates the screening of large peptide libraries, offering faster discovery times for relevant peptide leads based on affinity and functional screens.
Which Players Are Present In The Antisense & RNAi Therapeutics Market Space?
Major companies operating in the antisense & rnai therapeutics market are Biogen Inc., Ionis Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Moderna Inc., Sanofi S.A., Dicerna Pharmaceuticals Inc., Arbutus Biopharma Corporation, Acuitas Therapeutics, Adhera Therapeutics Inc., EdiGene Inc., Sirnaomics Inc., Suzhou Ribo Life Science Co. Ltd, Biocon Limited, Quark Pharmaceuticals, GlaxoSmithKline Plc, Shanghai Junshi Biosciences Co. Ltd., AstraZeneca, Benitec Biopharma Limited, Silence Therapeutics, Dynacure, CN Bio Innovations, Sarepta Therapeutics, Mallinckrodt, Regeneron Pharmaceuticals Inc., Alcyone Lifesciences Inc., Bio-Path Holdings Inc, Calando Pharmaceuticals, Enzon Pharmaceuticals Inc, Celnova Pharma, Pfizer Inc., Taiba Pharma, Gen İlaç ve Sağlık Ürünleri A.Ş., Egypt Otsuka Pharmaceutical
Get The Full Antisense & RNAi Therapeutics Market Report:
Which Region Accounts For The Largest Portion Of The Antisense & RNAi Therapeutics Market?
North America was the largest region in the antisense & RNAi therapeutics market in 2025. The regions covered in the antisense & rnai therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Antisense & RNAi Therapeutics Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Antisense & RNAi Therapeutics Market 2026, By The Business Research Company
Antisense And Rnai Therapeutics Market Report 2026
Rna Targeting Small Molecules Therapeutics Market Report 2026
Mrna Therapeutics Market Report 2026
https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model